MAPT and Alzheimer disease: This review also described how the exosomes extracted from bodily fluids, including CSF, plasma, urinary, or salivary exosomes, carry various diagnostic molecules, such as Aβ40, Aβ42, tTau, and p-Tau, which are also considered as biomarkers of CSF in AD diagnosis.